HAEMONETICS CORP/MASS (HAE)
US4050241003 - Common Stock
Haemonetics (HAE) Shares Cross Above 200 DMA
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00...
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Bullish Two Hundred Day Moving Average Cross - HAE
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to...
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the...
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's...
Haemonetics beats Q3 top and bottom line estimates, updates guidance (NYSE:HAE)
Haemonetics reported better-than-expected earnings and revenue in Q3.
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2024, which ended December 30, 2023, are...
Oversold Conditions For Haemonetics (HAE)
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2024 financial results at 6:00 am...
Notable Tuesday Option Activity: HAE, ABT, AZO
HAE Makes Bullish Cross Above Critical Moving Average
Haemonetics Corporation Completes Acquisition of OpSens Inc.
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
HAEMONETICS COMPLETES ACQUISITION OF OPSENS
/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS
/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare...
Commit To Buy Haemonetics At $75, Earn 11.1% Annualized Using Options
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS
/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...
Haemonetics is Now Oversold (HAE)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED
All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...
HAE Crosses Below Key Moving Average Level
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Intuitive Surgical stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an increase from 74 to 85.
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION
All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS
/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) announces that the Québec Superior Court (the "Court") issued an interim order...
(NYSE:HAE)
Haemonetics surpasses expectations in Q2 with Non-GAAP EPS of $0.99 (exceeding estimates by $0.10) and revenue of $318M (beating forecasts by $4.9M).
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2024, which ended September 30, 2023,...
Notable Wednesday Option Activity: RBLX, AVAV, HAE
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
Intuitive Surgical stock got an IBD rating upgrade Monday. It edged up 0.37% to 274.16, its second day in a row of rising share price.
Haemonetics to acquire OpSens in an all-cash deal (NYSE:HAE)
Haemonetics to acquire OpSens in a cash deal at C$2.90 per share, expanding its leadership in interventional cardiology and driving growth and...
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS
/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am...
Citi opens upside catalyst watch for Haemonetics ahead of earnings report (HAE)
Citi has opened an upside catalyst watch for Haemonetics ahead of the medtech's FYQ2 2024 earnings report and expects management to raise guidance. Read more here.
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
Intuitive Surgical stock dipped to an intraday low 180.07 in October last year as the bear market ended, then shot up to 358.07 on July 19.